Opportunity ID: 50992

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-09-505
Funding Opportunity Title: Limited Competition for the Continuation of the Pediatric Acute Liver Failure Study Group (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.847 — Diabetes, Endocrinology and Metabolism Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 07, 2010
Last Updated Date:
Original Closing Date for Applications: Mar 15, 2010
Current Closing Date for Applications: Mar 15, 2010
Archive Date: Apr 15, 2010
Estimated Total Program Funding: $17,100,000
Award Ceiling: $700,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Private institutions of higher education
Additional Information on Eligibility:

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. This Funding Opportunity Announcement (FOA) issued by the NIDDK, National Institutes of Health is to invite a cooperative agreement (U01) application for the competing continuation of the Pediatric Acute Liver Failure Study Group.
Mechanism of Support. This FOA will utilize the NIH Cooperative Agreement (U01) grant mechanism.
Funds Available and Anticipated Number of Awards. The total amount of funding that the NIDDK expects to award through this announcement is $17.1 million for one award.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-09-505.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

2025-07-11T03:32:33-05:00

Share This Post, Choose Your Platform!

About the Author: